GlassScriptPhysician profile
Kevin Hunt
NPI 1487917514
$1,682.52
in general payments reported to CMS, 2019-2025
20 companies · $187 in 2025
The $187 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $421 · 2020: $110 · 2022: $404 · 2023: $183 · 2024: $378 · 2025: $187.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $748.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $747.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $420.36 | 2020-2024 | Xarelto |
| Pfizer INC. | $251.74 | 2019-2024 | |
| Abbvie INC. | $227.60 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $101.32 | 2019-2024 | Dificid, Zerbaxa, Recarbrio |
| E.R. Squibb & Sons, L.L.C. | $94.47 | 2019-2024 | Eliquis |
| Allergan, INC. | $81.19 | 2019 | |
| Scpharmaceuticals INC. | $64.48 | 2025 | |
| Lexicon Pharmaceuticals, INC. | $61.52 | 2023-2024 | Inpefa |
| Novartis Pharmaceuticals Corporation | $52.47 | 2019-2022 | |
| Glaxosmithkline, LLC. | $51.58 | 2019-2020 | |
| Ucb, INC. | $45.33 | 2022 | |
| Boston Scientific Corporation | $37.52 | 2024 | Watchman Flx |
| Otsuka America Pharmaceutical, INC. | $35.90 | 2019 | |
| Melinta Therapeutics, LLC | $34.60 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $29.52 | 2019-2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $28.79 | 2022 | |
| Baxter Healthcare | $19.96 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $17.80 | 2025 | Lifevest |
| Alexion Pharmaceuticals, INC. | $14.79 | 2019 | |
| Philips North America LLC | $11.58 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Hunt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.